BLYS Trademark
BLYS is a USPTO trademark filed by Human Genome Sciences, Inc.. Status: Cancelled.
Trademark Facts
| Mark | BLYS |
|---|---|
| Serial Number | 75792415 |
| Registration Number | 2871946 |
| Status | Cancelled |
| Filing Date | 1999-09-03 |
| Registration Date | 2004-08-10 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Human Genome Sciences, Inc. |
| Attorney of Record | Tracy-Gene G. Durkin |
| Prosecution Events | 30 |
| Latest Event | C8.. on 2011-03-11 |
Goods & Services
proteins for the treatment of immune deficiency syndromes, cancer, AIDS, infectious diseases, allergies, asthma and autoimmunity; nucleic acids for the treatment of immune deficiency syndromes, cancer, AIDS, infectious diseases, allergies, asthma and autoimmunity; pharmaceutical preparations containing proteins for the treatment of immune deficiency syndromes, cancer, AIDS, infectious diseases, allergies, asthma and autoimmunity; pharmaceutical preparations containing nucleic acids for the treatment of immune deficiency syndromes, cancer, AIDS, infectious diseases, allergies, asthma and autoimmunity; proteins for the enhancement of B cell activity and immunoglobulin production following organ transplant, bone marrow transplant, vaccine administration, immunosuppression, chemotherapy, radio therapy, antibiotic therapy, and gene therapy; nucleic acids for the enhancement of B cell activity and immunoglobulin production following organ transplant, bone marrow transplant, vaccine administration, immunosuppression, chemotherapy, radio therapy, antibiotic therapy, and gene therapy; pharmaceutical preparations containing proteins for the enhancement of B cell activity and immunoglobulin production following organ transplant, bone marrow transplant, vaccine administration, immunosuppression, chemotherapy, radio therapy, antibiotic therapy, and gene therapy; and pharmaceutical preparations containing nucleic acids for the enhancement of B cell activity and immunoglobulin production following organ transplant, bone marrow transplant, vaccine administration, immunosuppression, chemotherapy, radio therapy, antibiotic therapy, and gene therapy